Target intelligence / Profile preview

Chemokine (C-C motif) ligand 24 (CCL24)

Target
CCL24
Molecular classification
Chemokine, Cytokine, Small secreted protein, CC chemokine family member
01

Overview

Chemokine (C-C motif) ligand 24 is a member of the CC chemokine family, distinguished by the presence of two adjacent cysteines. Primarily secreted by monocytes, macrophages, and bronchial epithelial cells, CCL24 exerts a strong chemotactic influence on eosinophils and, to a lesser degree, resting T lymphocytes and neutrophils. Its biological activity is closely linked to inflammatory and allergic disorders, where elevated levels are a hallmark of disease. CCL24 interacts with the chemokine receptor CCR3 to mediate immune cell recruitment in tissues. The molecule has demonstrated implications not only in the regulation of inflammation but also in disease modulation, such as diabetic nephropathy, by controlling tissue infiltration of immune cells and fibrosis. Research into CCL24 as a therapeutic target seeks to reduce pathological inflammation in severe allergic and chronic inflammatory conditions.

Other names
eotaxin-2MPIF-2myeloid progenitor inhibitory factor 2
02

Mechanism of action

Drugs or antibodies targeting CCL24 typically act by inhibiting its binding to CCR3 receptor, thereby reducing eosinophil and lymphocyte chemotaxis and subsequent inflammation

03

Biological functions

Chemotaxis of eosinophilsChemotaxis of resting T lymphocytesRegulation of inflammatory processesSuppression of colony formation by multipotential hematopoietic progenitor cells
04

Disease associations

Allergic disorders (including asthma, aspirin-exacerbated respiratory disease, atopic dermatitis)Chronic inflammatory diseases (including diabetic nephropathy)
05

Safety considerations

Potential immunosuppression and interference with host defense against infection if CCL24-targeted therapies excessively inhibit chemotaxis and the immune response
06

Biomarkers

Elevated CCL24 levels are found in the plasma/serum of patients with asthma, aspirin-exacerbated respiratory disease, and diabetic nephropathy, making it a candidate biomarker for these diseases

Beyond the preview

Go deeper on Chemokine (C-C motif) ligand 24 (CCL24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chemokine (C-C motif) ligand 24 (CCL24).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call